Nivolumab Trial Failure Raises the Question of Brain Imaging in Kidney Cancer

Nivolumab had limited efficacy against previously untreated brain metastases in patients with metastatic renal cell carcinoma, according to recent trial results.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news